TSE:TH Theratechnologies (TH) Stock Price, News & Analysis C$4.47 -0.23 (-4.89%) As of 09/26/2025 Add Compare Share Share Stock Analysis Stock AnalysisInsider TradesBuy This Stock About Theratechnologies Stock (TSE:TH) Get Theratechnologies alerts:Sign Up Key Stats Today's RangeC$4.36▼C$4.5350-Day RangeC$4.47▼C$4.4752-Week RangeC$1.59▼C$4.73Volume35,472 shsAverage Volume75,081 shsMarket CapitalizationC$205.53 millionP/E RatioN/ADividend Yield3.76%Price TargetN/AConsensus RatingN/A Company Overview Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. Read More Receive TH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TH Stock News HeadlinesTheratechnologies Gains Support for Future Pak AcquisitionSeptember 11, 2025 | theglobeandmail.comTheratechnologies receives interim order in acquisition by CB BiotechnologyAugust 18, 2025 | msn.comALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I.Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's latest AI patent as the catalyst behind their next major call. They say a market pattern with a 100% historical track record is converging with this new breakthrough by end of month. The last time conditions aligned like this, investors had the chance to turn $10,000 into as much as $350,000 in roughly 12 months. Brown and Chaikin have released the full details for investors who want to get ahead of it.August 6 at 1:00 AM | Brownstone Research (Ad)A Look at Theratechnologies's Upcoming Earnings ReportJuly 8, 2025 | benzinga.comWhat To Expect From Theratechnologies Inc (TSX:TH) Q2 2025 EarningsJuly 8, 2025 | finance.yahoo.comTheratechnologies Shares Surge Premarket on Deal to Go PrivateJuly 4, 2025 | marketwatch.comTheratechnologies shares surge 25% amid $254m Future Pak takeoverJuly 4, 2025 | msn.comTheratechnologies Inc. (TH.TO)May 31, 2025 | finance.yahoo.comSee More Headlines TH Stock Analysis - Frequently Asked Questions How have TH shares performed this year? Theratechnologies' stock was trading at C$4.47 on January 1st, 2026. Since then, TH shares have increased by 0.0% and is now trading at C$4.47. How do I buy shares of Theratechnologies? Shares of TH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Theratechnologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Theratechnologies investors own include Theratechnologies (THTX), BCE (BCE), ProMetic Life Sciences (PLI), Teranga Gold (TGZ), Vanguard Extended Duration Treasury ETF (EDV) and Industry, Sector and Symbol Stock ExchangeTSE SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolTSE:TH CIKN/A Webwww.theratech.com Phone+1-514-3367800FaxN/AEmployees103Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.19) Trailing P/E RatioN/A Forward P/E Ratio149.68 P/E Growth-8.5Net Income-C$1.96 million Net Margins-11.81% Pretax MarginN/A Return on Equity16.59% Return on Assets5.15% Debt Debt-to-Equity Ratio-156.22 Current Ratio0.84 Quick Ratio0.64 Sales & Book Value Annual SalesC$84.38 million Price / Sales2.44 Cash FlowC$1.19 per share Price / Cash Flow3.76 Book ValueC($0.57) per share Price / Book-7.90Miscellaneous Outstanding Shares45,980,000Free FloatN/AMarket CapC$205.53 million OptionableNot Optionable Beta0.26 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (TSE:TH) was last updated on 8/6/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredThe dollar reset no one told you aboutPorter Stansberry says a dollar reset is underway - one that has happened only once before in America's 250-ye...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHe bet half his $9 billion on ONE stockOne of the most successful fund managers of the past 50 years put more than $4.5 billion - over half his fund ...Stansberry Research | SponsoredTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredWhite House Insider: “President Trump is Getting Backstabbed!”A high-level White House insider and lifelong friend of the Trump family recently went on camera with a warnin...Paradigm Press | SponsoredThis under $7 stock could be.Just one mile from SpaceX's launchpad sits a small company doing something SpaceX can't - and it still trades ...Freedom Financial | SponsoredNew Dollar Plan Could Drain Your Account (Silently)Washington's so-called 'Mar-a-Lago Accord' aims to deliberately weaken the U.S. dollar to boost exports and br...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theratechnologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
